AR109354A2 - Una composición que comprende un compuesto bicíclico y compuesto - Google Patents

Una composición que comprende un compuesto bicíclico y compuesto

Info

Publication number
AR109354A2
AR109354A2 ARP170102288A ARP170102288A AR109354A2 AR 109354 A2 AR109354 A2 AR 109354A2 AR P170102288 A ARP170102288 A AR P170102288A AR P170102288 A ARP170102288 A AR P170102288A AR 109354 A2 AR109354 A2 AR 109354A2
Authority
AR
Argentina
Prior art keywords
compound
composition according
glyceride
composition
bicyclic
Prior art date
Application number
ARP170102288A
Other languages
English (en)
Inventor
Tsuyoshi Habe
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22573018&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR109354(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of AR109354A2 publication Critical patent/AR109354A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems

Abstract

Composición que comprende un compuesto bicíclico, de fórmula (1), que se espera que sea farmacéuticamente activo y un glicérido. Reivindicación 2: La composición de acuerdo con la reivindicación 1, caracterizada porque el glicérido es un glicérido de un ácido graso que tiene 6 - 24 átomos de carbono. Reivindicación 5: La composición de acuerdo con la reivindicación 1, caracterizada porque dicho glicérido se mezcla con el otro solvente oleoso. Reivindicación 6: La composición de acuerdo con la reivindicación 5, caracterizada porque el otro solvente oleoso mencionado es un aceite mineral. Reivindicación 8: La composición de acuerdo con la reivindicación 7, caracterizada porque es formulada como cápsula. Reivindicación 10: La composición de acuerdo con la reivindicación 9, caracterizada porque es formulada como gotas oftálmicas.
ARP170102288A 1999-10-15 2017-08-16 Una composición que comprende un compuesto bicíclico y compuesto AR109354A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15954999P 1999-10-15 1999-10-15

Publications (1)

Publication Number Publication Date
AR109354A2 true AR109354A2 (es) 2018-11-21

Family

ID=22573018

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP000105407A AR026046A1 (es) 1999-10-15 2000-10-13 NUEVA COMPOSICIoN Y MÉTODO PARA ESTABILIZAR LA MISMA
ARP130100275A AR089848A2 (es) 1999-10-15 2013-01-30 Un compuesto biciclico, composicion farmaceutica y metodo para estabilizarlo
ARP170102288A AR109354A2 (es) 1999-10-15 2017-08-16 Una composición que comprende un compuesto bicíclico y compuesto

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ARP000105407A AR026046A1 (es) 1999-10-15 2000-10-13 NUEVA COMPOSICIoN Y MÉTODO PARA ESTABILIZAR LA MISMA
ARP130100275A AR089848A2 (es) 1999-10-15 2013-01-30 Un compuesto biciclico, composicion farmaceutica y metodo para estabilizarlo

Country Status (26)

Country Link
US (5) US6583174B1 (es)
EP (2) EP1426361B2 (es)
JP (2) JP4332316B2 (es)
KR (1) KR100830061B1 (es)
CN (1) CN1268623C (es)
AR (3) AR026046A1 (es)
AT (2) ATE267189T1 (es)
AU (2) AU780342B2 (es)
BR (1) BRPI0014869B8 (es)
CA (1) CA2385732C (es)
CZ (1) CZ303625B6 (es)
DE (2) DE60039727D1 (es)
DK (2) DK1426361T4 (es)
ES (2) ES2309410T5 (es)
HK (2) HK1066792A1 (es)
HU (2) HU230484B1 (es)
IL (2) IL148803A0 (es)
MX (1) MXPA02003756A (es)
NO (1) NO330258B1 (es)
NZ (1) NZ518020A (es)
PT (2) PT1426361E (es)
RU (1) RU2695274C3 (es)
TR (1) TR200201032T2 (es)
TW (1) TWI281918B (es)
WO (1) WO2001027099A2 (es)
ZA (1) ZA200202312B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2385732C (en) * 1999-10-15 2009-02-10 Sucampo Ag Bicyclic compounds composition and method for stabilizing the same
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI331920B (en) * 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
FR2842810B1 (fr) * 2002-07-25 2006-01-27 Inst Nat Sciences Appliq Nouveaux composes gem difluores, leur procedes de preparation et leurs applications.
US8114911B2 (en) * 2002-10-23 2012-02-14 Sucampo Ag Prostaglandin compounds for the treatment of obesity
WO2004060377A1 (en) * 2002-12-27 2004-07-22 Sucampo Ag Derivatives of prostaglandins for treating abdominal discomfort
US8337891B2 (en) * 2003-07-03 2012-12-25 Sucampo Ag Enteric coated composition comprising prostaglandin analogs as chloride channel opener
TWI495471B (zh) * 2003-08-12 2015-08-11 R Tech Ueno Ltd 促進毛髮生長之組成物及方法
TWI387454B (zh) 2004-09-02 2013-03-01 Sucampo Ag 治療胃腸道疾病之方法及組成物
PL1871380T3 (pl) * 2005-04-12 2012-03-30 Sucampo Ag Zastosowanie kombinacji związku prostaglandyny i inhibitora pompy protonowej w leczeniu zaburzeń żołądkowo-jelitowych
DK1978944T3 (da) 2006-01-24 2012-11-05 Sucampo Ag Blød-gelatine-kapselformulering
KR20140147142A (ko) * 2006-01-24 2014-12-29 가부시키가이샤 아루떼꾸 우에노 바이-사이클릭 화합물을 함유하는 약학적 조성물 및 바이-사이클릭 화합물의 안정화 방법
EP1981867B1 (en) * 2006-02-07 2017-06-14 R-Tech Ueno, Ltd. Method for preparing prostaglandin derivative
US20090012165A1 (en) 2007-07-03 2009-01-08 Sucampo Ag Pharmaceutical combination of nsaid and prostaglandin compound
US20090030072A1 (en) 2007-07-03 2009-01-29 Sucampo Ag Pharmaceutical combination of opioid and prostaglandin compound
KR101485212B1 (ko) * 2007-07-19 2015-01-22 가부시키가이샤 아루떼꾸 우에노 11-데옥시-프로스타글란딘 화합물을 포함하는 약학 조성물 및 상기 화합물을 안정화시키는 방법
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
CN101318948B (zh) 2008-04-01 2011-04-27 上海天伟生物制药有限公司 鲁比前列酮晶体、其制备方法及用途
US8569279B2 (en) * 2009-05-27 2013-10-29 Sucampo Ag Method for modulating claudin mediated functions
US20110034424A1 (en) * 2009-06-30 2011-02-10 Sucampo Ag Method for the long term nsaid use
DK2653468T3 (en) 2009-07-28 2016-06-06 Ono Pharmaceutical Co Bicyclic compound AND USE THEREOF FOR MEDICAL PURPOSES
TW201118084A (en) * 2009-09-18 2011-06-01 Adolor Corp The use of an opioid receptor antagonist for the treatment or prevention of gastrointestinal tract disorders
US8940790B2 (en) 2009-11-03 2015-01-27 Bernard Charles Sherman Stable pharmaceutical formulations comprising lubiprostone
EP2669280B1 (en) 2011-01-27 2016-04-27 ONO Pharmaceutical Co., Ltd. Bicyclic compound and use thereof for medical purposes
EP2669279B1 (en) 2011-01-27 2017-01-11 ONO Pharmaceutical Co., Ltd. Bicyclic compound and use thereof for medical purposes
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
US10736871B2 (en) 2015-04-01 2020-08-11 Cedars-Sinai Medical Center Anti-methanogenic lovastatin analogs or derivatives and uses thereof
JP6954282B2 (ja) 2016-06-30 2021-10-27 小野薬品工業株式会社 二環式化合物の製造方法
US11534404B2 (en) 2016-10-06 2022-12-27 Sucampo Ag Multilayer beads for pharmaceutical use
JPWO2019221215A1 (ja) * 2018-05-18 2021-05-27 ニプロ株式会社 ルビプロストン含有粒子状医薬組成物

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US18202A (en) * 1857-09-15 Improvement in feathering paddle-wheels
JPS5720305B2 (es) 1973-02-28 1982-04-27
US4034003A (en) 1974-04-11 1977-07-05 Ono Pharmaceutical Co., Ltd. 15-Cycloalkyl-prostaglandins
US3966962A (en) * 1975-03-27 1976-06-29 The Upjohn Company Triacetin solutions of PGE-type compounds
JPS5350141A (en) * 1976-10-18 1978-05-08 Ono Pharmaceut Co Ltd Stabilization of prostaglandin and prostaglandin analogues
JPS5919524B2 (ja) 1976-12-17 1984-05-07 中外製薬株式会社 安定な１α−ヒドロキシビタミンＤ類含有製剤
JPS5391110A (en) 1977-01-20 1978-08-10 Yamanouchi Pharmaceut Co Ltd Novel drug composition for rectal infusion
CA1184906A (en) * 1977-04-19 1985-04-02 Roy A. Johnson 9-deoxy-5,9-epoxy-prostaglandins
JPS6022708B2 (ja) 1977-07-14 1985-06-03 小野薬品工業株式会社 プロスタグランジン類似化合物
JPS5452717A (en) * 1977-09-29 1979-04-25 Chugai Pharmaceut Co Ltd Stable oily pharmaceuticals containing 1alpha-hydroxyvitamin d
US4130566A (en) * 1977-10-27 1978-12-19 Sumitomo Chemical Company, Limited Process for producing 5-carboxy-2-acetylthiophene
AT358530B (de) 1978-04-25 1980-09-10 Plc Pharma Licences Stabilisierungsverfahren
JPS55136219A (en) 1979-04-11 1980-10-23 Sumitomo Chem Co Ltd Diazepam oily drug
US4670569A (en) 1981-04-02 1987-06-02 G. D. Searle & Co. 5-fluoro-PGI2 compounds
JPS59137413A (ja) * 1983-01-25 1984-08-07 Teijin Ltd ７−チアプロスタグランジンｅ↓１類を含有する医薬品組成物
US4687864A (en) 1983-12-23 1987-08-18 G. D. Searle & Co. 5-fluoro-3-oxa-prostacyclin compounds
US4579958A (en) 1983-12-23 1986-04-01 G. D. Searle & Co. 5-fluoro-3-oxa-6,7-didehydro-PGI1 compounds
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
US5380709A (en) 1987-01-28 1995-01-10 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5225439A (en) 1987-01-28 1993-07-06 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US4758880A (en) 1987-03-27 1988-07-19 The Grass Valley Group, Inc. Video matte generator
DE3851152T2 (de) 1987-09-03 1995-01-26 Univ Georgia Res Found Cyclosporin-augenmittel.
US5317032A (en) * 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
DE3873007T2 (de) 1987-10-02 1992-12-03 Ueno Seiyaku Oyo Kenkyujo Kk Kathartica.
JP2597649B2 (ja) † 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
DE68904358T2 (de) * 1988-06-17 1993-07-29 Wellcome Found Prostaglandinanaloge zur verwendung in der medizin.
JP2579193B2 (ja) 1988-07-19 1997-02-05 小野薬品工業株式会社 １６，１６−ジフルオロ−１５−オキソ−１５−デオキシｐｇｅ誘導体
JPH0745504B2 (ja) * 1988-07-29 1995-05-17 株式会社上野製薬応用研究所 プロスタグランジン前駆体およびその製法
JP2794433B2 (ja) 1989-02-02 1998-09-03 丸善製薬株式会社 甘草疎水性フラボノイド製剤
CA2030346C (en) † 1989-11-22 2000-04-11 Ryuji Ueno Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
CA2030344C (en) * 1989-11-22 2000-04-18 Ryuji Ueno Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
US5256696A (en) * 1989-11-22 1993-10-26 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds
CA2041417C (en) 1990-05-01 2002-05-21 Ryuji Ueno Treatment of pancreatic disease with 15-keto-prostaglandin compounds
JPH0446122A (ja) 1990-06-13 1992-02-17 Nippon Iyakuhin Kogyo Kk 活性型ビタミンｄ↓３類含有製剤
CA2046069C (en) 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
JP2938579B2 (ja) 1990-12-15 1999-08-23 株式会社上野製薬応用研究所 消化管壁保護剤
US5274130A (en) * 1991-09-03 1993-12-28 R-Tech Ueno Ltd. Process for production of prostaglandin intermediates
JP2746800B2 (ja) * 1991-09-03 1998-05-06 株式会社アールテック・ウエノ プロスタグランジン中間体の製法
US5474979A (en) 1994-05-17 1995-12-12 Allergan, Inc. Nonirritating emulsions for sensitive tissue
CA2150287C (en) 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
US5981607A (en) 1998-01-20 1999-11-09 Allergan Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
CA2385732C (en) * 1999-10-15 2009-02-10 Sucampo Ag Bicyclic compounds composition and method for stabilizing the same
US6414016B1 (en) 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
JP4210631B2 (ja) 2004-06-24 2009-01-21 株式会社日立製作所 ブレーキ制御装置

Also Published As

Publication number Publication date
KR100830061B1 (ko) 2008-05-16
AU2004242503C1 (en) 2005-01-27
WO2001027099A3 (en) 2001-10-25
BR0014869A (pt) 2002-06-25
ATE267189T1 (de) 2004-06-15
CZ20021037A3 (cs) 2002-09-11
ZA200202312B (en) 2002-12-24
DE60010913T2 (de) 2005-06-09
CA2385732A1 (en) 2001-04-19
EP1220849A2 (en) 2002-07-10
ATE402925T2 (de) 2008-08-15
JP4332316B2 (ja) 2009-09-16
US8088934B2 (en) 2012-01-03
WO2001027099A2 (en) 2001-04-19
HK1066792A1 (en) 2005-04-01
EP1220849B1 (en) 2004-05-19
CN1379769A (zh) 2002-11-13
CN1268623C (zh) 2006-08-09
HUP1300369A2 (es) 2003-03-28
IL148803A (en) 2006-07-05
EP1426361B1 (en) 2008-07-30
TR200201032T2 (tr) 2002-08-21
AR026046A1 (es) 2002-12-26
US20080255227A1 (en) 2008-10-16
DK1220849T3 (da) 2004-09-27
KR20020068521A (ko) 2002-08-27
CA2385732C (en) 2009-02-10
HU230484B1 (hu) 2016-07-28
RU2695274C3 (ru) 2020-11-09
EP1426361B2 (en) 2015-02-25
JP2009235079A (ja) 2009-10-15
EP1426361A1 (en) 2004-06-09
US20040235885A1 (en) 2004-11-25
DK1426361T4 (en) 2015-03-16
HK1045693A1 (en) 2002-12-06
NO20021736L (no) 2002-04-12
AR089848A2 (es) 2014-09-24
US7417067B2 (en) 2008-08-26
US8097649B1 (en) 2012-01-17
RU2695274C9 (ru) 2020-01-22
DE60039727D1 (de) 2008-09-11
AU2004242503A1 (en) 2005-01-27
PT1426361E (pt) 2008-10-08
AU7685600A (en) 2001-04-23
HUP0203746A3 (en) 2005-02-28
US6583174B1 (en) 2003-06-24
HUP0203746A2 (hu) 2003-03-28
AU2004242503B2 (en) 2007-06-21
NO330258B1 (no) 2011-03-14
ES2221859T3 (es) 2005-01-16
NZ518020A (en) 2004-02-27
BRPI0014869B8 (pt) 2021-05-25
ES2309410T3 (es) 2008-12-16
HK1045693B (zh) 2005-01-21
DK1426361T3 (da) 2008-11-17
HU229547B1 (en) 2014-01-28
ES2309410T5 (es) 2015-03-17
DE60010913D1 (de) 2004-06-24
IL148803A0 (en) 2002-09-12
AU780342B2 (en) 2005-03-17
PT1220849E (pt) 2004-10-29
TWI281918B (en) 2007-06-01
RU2002112984A (ru) 2004-01-20
BRPI0014869B1 (pt) 2017-06-13
CZ303625B6 (cs) 2013-01-16
NO20021736D0 (no) 2002-04-12
JP2003511445A (ja) 2003-03-25
MXPA02003756A (es) 2005-09-08
US20120095090A1 (en) 2012-04-19
RU2695274C2 (ru) 2019-07-22

Similar Documents

Publication Publication Date Title
AR109354A2 (es) Una composición que comprende un compuesto bicíclico y compuesto
ATE292460T1 (de) Zusammenstellungen die aktive stilbenoidverbindungen enthalten zur senkung des triglyceridspiegels
BR0313876A (pt) Uso de uma mistura, composições de combustìvel e de solvente, e, processo para a preparação de uma mistura
CA2251366A1 (en) Controlled gel breaker
AR048017A1 (es) Composicion y metodo para aumentar la biodisponibilidad
BR0008177A (pt) Ëleos com comprimentos de cadeia heterogêneos
NZ536960A (en) Hand and skin cleansing formulation
DE60237358D1 (es)
AR018386A1 (es) Método para preparar una composicion colectora de minerales.
PE20030742A1 (es) Composiciones farmaceuticas de derivados de taxano oralmente activos que tienen biodisponibilidad mejorada
CO5700779A2 (es) Un proceso para la preparación de oxi-(1h)-quinolin-2-onas 5-(haloacetil)-8-sustituidas
TR200102861T2 (tr) Uzun zincirli trigliseridler ve lipofilik surfaktantları içeren oral farmasötik kompozisyonlar.
CO5570649A2 (es) Producto antitranspirante en gel liquido de alta eficiencia
AR012764A1 (es) Compuestos derivados de la eritromicina, composiciones que los contienen, usos y procedimientos para prepararlos.
GT200200065A (es) Composicion parenteral reconstituible
AR029145A1 (es) Compuesto de hidroxamato pirrolidina sustituida, inhibidores de metaloproteasa, composicion farmaceutica que lo comprende y uso para elaborar una composicion farmaceutica
EA199900303A2 (ru) Замещенные трициклические соединения
AR023552A1 (es) Proceso para extraer los acidos grasos libres de las grasas y los aceites de origen biologico o sus destilados
PE20020833A1 (es) Composiciones quimioterapicas de paclitaxel en microemulsion con mayor biodisponisibilidad oral
PE20020909A1 (es) Una combinacion que comprende combretastatina y agentes anticancerigenos
ES2111269T3 (es) Procedimiento de extraccion de compuestos malolientes presentes en una formulacion que contiene al menos un compuesto que comprende un grupo tiol y composiciones desodorizadas asi obtenidas.
UY28524A1 (es) Derivados de triazol sustituidos como antagonistas de oxitocina
ES2179332T3 (es) Repelentes de artropodos.
EA199900304A2 (ru) Замещенные трициклические соединения
AR027342A1 (es) Aceites lubricantes